FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference.
作者信息
Piketty Marie-Liesse, Brabant Severine, Souberbielle Jean-Claude, Maruani Gérard, Audrain Christelle, Rothenbuhler Anya, Prié Dominique, Linglart Agnès
机构信息
AP-HP, Department of Functional Explorations, Necker Enfants Malades Hospital, Paris-Centre University, Paris Cedex, France.
AP-HP, Department of Endocrinology and Diabetology for children and Department of Adolescent Medicine, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filière OSCAR and Platform of Expertise for Rare Diseases Paris-Sud, Bicêtre Paris-Saclay Hospital, Paris Saclay University, Le Kremlin-Bicêtre, France.
出版信息
Clin Chem Lab Med. 2020 Oct 25;58(11):e267-e269. doi: 10.1515/cclm-2020-0460.
PMID:32653872
Abstract
摘要
Zotero 插件